Reconvened Sixty-fifth session of the Commission on Narcotic Drugs, Vienna, Austria, 8-9 December 2022 CCPCJ Chair: Good Morning. (Opening Statement) >>> CND dates 2023 March 13 – 17 CND Chair: Opening Statement (Agenda adopted) Agenda Item 4. Strategic management, budgetary and administrative questions, including the following sub-items: (a) Work of the standing open-ended intergovernmental working …
Colombia
CND Chair one-day special forum on availability and access to controlled substances for medical and scientific purposes
Chair: I welcome our panelists. We all know how severe this issue is – medicines are unavailable or unaffordable. This is for a variety of reasons, some of it is regulatory – lets not forget that there is a lot of weork done to optimize legislation. There is also often a lack of professional knowledge. …
Special commemorative event at the occasion of the United Nations International Day against Drug Abuse and Illicit Trafficking and Launch of the 2022 World Drug Report
Chair: Welcome. Today, to promote participation, we are conducting this meeting in a hybrid format. I welcome all our panelists, youth ambassadors, and the 26 registered speakers. WDR is historically launched on World Drug Day which is a very important day for us all to advance SDGs and build back better. The theme this year …
Plenary Item 12. Adoption of the report of the Commission on its sixty-fifth session.
Chair: We are having technical difficulties with printing the resolutions, we will therefore change the order of our proceedings, but we will turn to Nigeria who has kindly agreed to act as rapporteur so that we can adopt various parts of the report. We will then move to the resolutions. We only have a few …
Committee of the Whole L5. Promoting comprehensive and scientific evidence-based early prevention
Slovenia: we had constructive informals that redefined the word ‘flexibility’ but we thank all delegates for their constructive approach. We confirmed to delete PP11bis, amend PP11ter and this is agreed in informals. Chair: What is the feeling of the room regarding PP11bis and PP11ter? Are there any comments? I see none. Let’s consider both agreed …
Committee of the Whole L7. Intensifying efforts to address the proliferation of uncontrolled and designer precursors used in the illicit manufacture of drugs
Secretariat: There will be an informal on L5 in a hybrid format on BR-A. L7 – Technical amendment. On OP12 & 13 – There is in square brackets ‘or trafficking’. There was an omission to delete this part. Just checking with the CoW. Ok, we can continue. United States: We engaged in consultations, not in …